-1366x0.jpg)
At the VSSM 2024 Conference, Dr. Pham Dinh Minh stated that there are numerous factors contributing to abnormalities in sexual development, including genetic and environmental influences. Nowadays, the most effective method for screening and diagnosing genetic abnormalities related to sexual development is through testing.
Additionally, Dr. Minh provided distinguished conference attendees with information on several tests that aid in screening and accurately diagnosing abnormalities in sexual development, thereby helping clinicians determine treatment plans for individual patients. He shared details about some advanced tests in this field that GENTIS is implementing currently.
These include embryo screening with PGTest, non-invasive prenatal screening NIPT GenEva, karyotyping, testing for the presence/mutations of genes such as AZF, the cystic fibrosis gene CFTR, mutations in the SRD5A2 gene, and panel gene for male infertility,... These genetic tests serve as a guiding framework for clinicians to diagnose the underlying causes of sexual development abnormalities and to select appropriate treatment options for patients.
Dr. Pham Dinh Minh (Director of R&D at GENTIS) presented a report titled “Genetic Testing for Identifying Abnormalities in Sexual Development and the Fundamental Principles for Genetic Counseling.”
In addition, Dr. Minh emphasized the importance of genetic counseling in managing and caring for patients with sexual development abnormalities. He noted that in line with global trends, the GENTIS Genetic Counseling Center was established with a highly specialized team of geneticists and doctors to provide genetic counseling support. The center acts as a bridge between clinicians and genetic testing laboratories, collaborating with other specialties to diagnose and manage sexual development abnormalities as well as other genetic disorders.
This presentation garnered significant attention from distinguished attendees at the conference due to its relevance and practical implications for the examination and treatment of sexual development abnormalities nowadays.
In recent years, the field of Sexology has received special attention from both professionals and the community. The VSSM 2024 program featured 48 scientific presentations on in-depth research topics such as hypogonadism, male and female sexual health,... while also updating on international news and achievements in Sexology. The chairmen and speakers included Professors, Associate Professors, Doctors, and leading Physicians in the field of Sexology from across the country.
.
Mai Ba Tien Dung, Ph.D., M.D - Binh Dan Hospital presented a report titled “Survey of Gene Mutations in the Non-Obstructive Azoospermia Patient Group Using Next-Generation Sequencing Technology”
Currently, the rate of male infertility is rising, but not all cases are due to common causes such as AZF microdeletions or CFTR gene mutations. Various other factors contribute to male infertility, including non-obstructive azoospermia, high rates of sperm abnormalities, poor motility, and suboptimal spermatogenesis,... which may be linked to mutations in genes such as AK7, AR, AKR1C4, BRDT, FSHB, and FSHR,... Investigating these genes can often be challenging and costly. At GENTIS, the Fertiscan test analyzes 120 genes simultaneously to evaluate genetic causes of infertility in both males and females. GENTIS is the first unit in Vietnam to implement this test.
At the conference, the presentations in the Andrology session attracted significant interest from many attendees. Notably, Nguyen Tien Dung, M.Sc., M.D. (Viet Duc University Hospital) presented a report on "Sexually Transmitted Infections”. In this presentation, Dr. Dung provided detailed insights into the characteristics and causes of these infections, as well as methods for screening and diagnosing sexually transmitted diseases. Currently, testing is the only definitive way to confirm whether an individual is infected.
Nguyen Tien Dung, M.Sc., M.D. (Viet Duc University Hospital) presented a report on "Sexually Transmitted Infections”.
Remarkably, Dr. Dung highly praised GENTIS's STD testing, which simultaneously identifies 12 pathogens responsible for sexually transmitted infections. He explained that GENTIS employs real time-PCR technology to detect and quantify viral and bacterial DNA in samples from urine, urethral discharge, and vaginal swabs using the PANA RealTyper™ STD kit (PANAGENE), which has received IVD certification with sensitivity and specificity exceeding 99%. This approach optimizes accurate diagnostic timing for doctors and reduces costs for patients. The presentation was considered highly practical, accurately reflecting the current needs in the field of andrology in Vietnam.
With the aim of further development, GENTIS hopes to receive more collaborations from doctors and experts to expand the presence in the fields of andrology and sexology. As a sponsor, GENTIS had the opportunity to introduce the leading testing services to esteemed doctors and specialists in andrology, sexology, and obstetrics.
GENTIS was delighted to see the attendees at the VSSM 2024 Conference show interest in the company’s booth. In particular, when visiting the GENTIS booth, doctors and experts had the opportunity to participate in a mini-game and a lucky wheel, receiving valuable gifts such as Sperm DNA testing vouchers and books on male infertility,...
VSSM 2024 provided GENTIS with an opportunity to update the knowledge in the fields of obstetrics, andrology, and sexology, as well as to learn lots of experiences ,and gain valuable insights from experts to enhance service quality. Moreover, it was also a chance for GENTIS to network and directly introduce the services to esteemed delegates. GENTIS hopes to make a contribution to the field of genetic testing in particular and to the overall advancement of the healthcare industry.
